Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

16,198 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
IL-6-mediated intersubgenotypic variation of interferon sensitivity in hepatitis C virus genotype 2a/2b chimeric clones.
Suda G, Sakamoto N, Itsui Y, Nakagawa M, Tasaka-Fujita M, Funaoka Y, Watanabe T, Nitta S, Kiyohashi K, Azuma S, Kakinuma S, Tsuchiya K, Imamura M, Hiraga N, Chayama K, Watanabe M. Suda G, et al. Among authors: watanabe t, watanabe m. Virology. 2010 Nov 10;407(1):80-90. doi: 10.1016/j.virol.2010.07.041. Epub 2010 Aug 25. Virology. 2010. PMID: 20797756 Free article.
Comparison of HCV-associated gene expression and cell signaling pathways in cells with or without HCV replicon and in replicon-cured cells.
Nishimura-Sakurai Y, Sakamoto N, Mogushi K, Nagaie S, Nakagawa M, Itsui Y, Tasaka-Fujita M, Onuki-Karakama Y, Suda G, Mishima K, Yamamoto M, Ueyama M, Funaoka Y, Watanabe T, Azuma S, Sekine-Osajima Y, Kakinuma S, Tsuchiya K, Enomoto N, Tanaka H, Watanabe M. Nishimura-Sakurai Y, et al. Among authors: watanabe t, watanabe m. J Gastroenterol. 2010 May;45(5):523-36. doi: 10.1007/s00535-009-0162-3. Epub 2009 Dec 12. J Gastroenterol. 2010. PMID: 20012654
Inhibitory effect of a triterpenoid compound, with or without alpha interferon, on hepatitis C virus infection.
Watanabe T, Sakamoto N, Nakagawa M, Kakinuma S, Itsui Y, Nishimura-Sakurai Y, Ueyama M, Funaoka Y, Kitazume A, Nitta S, Kiyohashi K, Murakawa M, Azuma S, Tsuchiya K, Oooka S, Watanabe M. Watanabe T, et al. Among authors: watanabe m. Antimicrob Agents Chemother. 2011 Jun;55(6):2537-45. doi: 10.1128/AAC.01780-10. Epub 2011 Mar 28. Antimicrob Agents Chemother. 2011. PMID: 21444704 Free PMC article.
Analysis of interferon signaling by infectious hepatitis C virus clones with substitutions of core amino acids 70 and 91.
Funaoka Y, Sakamoto N, Suda G, Itsui Y, Nakagawa M, Kakinuma S, Watanabe T, Mishima K, Ueyama M, Onozuka I, Nitta S, Kitazume A, Kiyohashi K, Murakawa M, Azuma S, Tsuchiya K, Watanabe M. Funaoka Y, et al. Among authors: watanabe t, watanabe m. J Virol. 2011 Jun;85(12):5986-94. doi: 10.1128/JVI.02583-10. Epub 2011 Apr 13. J Virol. 2011. PMID: 21490101 Free PMC article.
Serum interleukin-6 levels correlate with resistance to treatment of chronic hepatitis C infection with pegylated-interferon-α2b plus ribavirin.
Ueyama M, Nakagawa M, Sakamoto N, Onozuka I, Funaoka Y, Watanabe T, Nitta S, Kiyohashi K, Kitazume A, Murakawa M, Nishimura-Sakurai Y, Sekine-Osajima Y, Itsui Y, Azuma S, Kakinuma S, Watanabe M; Ochanomizu-Liver Conference Study Group. Ueyama M, et al. Among authors: watanabe t, watanabe m. Antivir Ther. 2011;16(7):1081-91. doi: 10.3851/IMP1864. Antivir Ther. 2011. PMID: 22024524
Antiviral effects of the interferon-induced protein guanylate binding protein 1 and its interaction with the hepatitis C virus NS5B protein.
Itsui Y, Sakamoto N, Kakinuma S, Nakagawa M, Sekine-Osajima Y, Tasaka-Fujita M, Nishimura-Sakurai Y, Suda G, Karakama Y, Mishima K, Yamamoto M, Watanabe T, Ueyama M, Funaoka Y, Azuma S, Watanabe M. Itsui Y, et al. Among authors: watanabe t, watanabe m. Hepatology. 2009 Dec;50(6):1727-37. doi: 10.1002/hep.23195. Hepatology. 2009. PMID: 19821486
Impaired induction of interleukin 28B and expression of interferon λ 4 associated with nonresponse to interferon-based therapy in chronic hepatitis C.
Murakawa M, Asahina Y, Nakagawa M, Sakamoto N, Nitta S, Kusano-Kitazume A, Watanabe T, Kawai-Kitahata F, Otani S, Taniguchi M, Goto F, Nishimura-Sakurai Y, Itsui Y, Azuma S, Kakinuma S, Watanabe M. Murakawa M, et al. Among authors: watanabe t, watanabe m. J Gastroenterol Hepatol. 2015 Jun;30(6):1075-84. doi: 10.1111/jgh.12902. J Gastroenterol Hepatol. 2015. PMID: 25611696
Association of ITPA gene variation and serum ribavirin concentration with a decline in blood cell concentrations during pegylated interferon-alpha plus ribavirin therapy for chronic hepatitis C.
Nakagawa M, Sakamoto N, Watanabe T, Nishimura-Sakurai Y, Onozuka I, Azuma S, Kakinuma S, Nitta S, Kiyohashi K, Kusano-Kitazume A, Murakawa M, Yoshino K, Itsui Y, Tanaka Y, Mizokami M, Watanabe M; Ochanomizu-Liver Conference Study Group. Nakagawa M, et al. Among authors: watanabe t, watanabe m. Hepatol Int. 2013 Mar;7(1):153-61. doi: 10.1007/s12072-012-9363-6. Epub 2012 Mar 21. Hepatol Int. 2013. PMID: 26201629
Evaluation of Interferon Resistance in Newly Established Genotype 1b Hepatitis C Virus Cell Culture System.
Taniguchi M, Tasaka-Fujita M, Nakagawa M, Watanabe T, Kawai-Kitahata F, Otani S, Goto F, Nagata H, Kaneko S, Nitta S, Murakawa M, Nishimura-Sakurai Y, Azuma S, Itsui Y, Mori K, Yagi S, Kakinuma S, Asahina Y, Watanabe M. Taniguchi M, et al. Among authors: watanabe t, watanabe m. J Clin Transl Hepatol. 2016 Mar 28;4(1):5-11. doi: 10.14218/JCTH.2015.00047. Epub 2016 Mar 15. J Clin Transl Hepatol. 2016. PMID: 27047766 Free PMC article.
Cholestatic liver fibrosis and toxin-induced fibrosis are exacerbated in matrix metalloproteinase-2 deficient mice.
Onozuka I, Kakinuma S, Kamiya A, Miyoshi M, Sakamoto N, Kiyohashi K, Watanabe T, Funaoka Y, Ueyama M, Nakagawa M, Koshikawa N, Seiki M, Nakauchi H, Watanabe M. Onozuka I, et al. Among authors: watanabe t, watanabe m. Biochem Biophys Res Commun. 2011 Mar 4;406(1):134-40. doi: 10.1016/j.bbrc.2011.02.012. Epub 2011 Feb 12. Biochem Biophys Res Commun. 2011. PMID: 21300023
16,198 results
You have reached the last available page of results. Please see the User Guide for more information.